BELLEVUE LIFE SCIENCES ACQUISITION CORP.

Bellevue Life Sciences Acquisition Corp.

BLAC

US0791741087

Investment Holding Companies

Market Closed - Nasdaq Other stock markets 02:00:00 23/05/2024 am IST			5-day change	1st Jan Change
10.73 ^USD	-.--%		-.--%	+2.19%

15/05	Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/05	Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding	CI

Bellevue Life Sciences Acquisition : New Financial Obligation - Form 8-K

April 23, 2024 at 01:55 am IST

Item 1.01.

Entry into a Material Definitive Agreement.

The information provided in Item 2.03 of this Current Report on Form 8-Kis incorporated by reference into this Item 1.01.

Attachments

Original Link
Permalink

Disclaimer

Bellevue Life Sciences Acquisition Corp. published this content on 22 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 April 2024 20:24:48 UTC.

Latest news about Bellevue Life Sciences Acquisition Corp.

Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding	14/05	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.05 million in funding	17/04	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $1.2 million in funding	08/04	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.06 million in funding	08/03	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.075 million in funding	09/02	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Certain Common Stock of Bellevue Life Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 9-AUG-2023.	09/23/09	CI
Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal	12/23/12	MT
Bellevue Life Sciences Acquisition Corp. entered into an exclusive, non-binding letter of intent to acquire OSR Holdings, Ltd.	11/23/11	CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.2 million in funding	23/23/23	CI
Bellevue Life Sciences Acquisition Corp. Announces the Resignation of Hosun Euh as Member of the Board of Directors, Effective June 21, 2023	15/23/15	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Bellevue Life Sciences Acquisition Corp. Auditor Raises 'Going Concern' Doubt	31/23/31	CI
Bellevue Life Sciences Acquisition Corp.(NasdaqCM:BLAC) added to NASDAQ Composite Index	20/23/20	CI
Bellevue Life Sciences Acquisition Corp. has completed an IPO in the amount of $60 million.	09/23/09	CI
Bellevue Life Sciences Acquisition Corp. has filed an IPO in the amount of $60 million.	29/22/29	CI

Chart Bellevue Life Sciences Acquisition Corp.

Duration

Period

Chart Bellevue Life Sciences Acquisition Corp.

More charts

Company Profile

Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
BELLEVUE LIFE SCIENCES ACQUISITION CORP.	+2.19%	60.33M
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+180.51%	8.67B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	883M
PERELLA WEINBERG PARTNERS	+26.17%	825M
ARES ACQUISITION CORPORATION II	+1.92%	665M
E7 GROUP	+9.52%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+9.17%	530M
CAPITOL INVESTMENT CORP. VII	-.--%	500M